CENTANY

LOE Approaching

mupirocin

NDATOPICALOINTMENT
Approved
Dec 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2

Mechanism of Action

CLINICAL PHARMACOLOGY Following the application of Centany (mupirocin ointment),2% to a 400 cm area on the back of 23 healthy volunteers once daily for 7 days, the mean (range) cumulative urinary excretion of monic acid over 24 hrs following the last administration was 1.25% (0.2% to 3.0%) of the…

Clinical Trials (2)

NCT00801879Phase 4Completed

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

Started Sep 2003
100 enrolled
Staphylococcus AureusHIV Infections
NCT00156377Phase 4Completed

Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections

Started Nov 2002
1,200 enrolled
Cross InfectionStaphylococcal Infections